Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-05-2002 | Original Article

Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results

Authors: Martin Gotthardt, Marc Fischer, Inga Naeher, Josefin B. Holz, Hartmut Jungclas, Hans-Walter Fritsch, Martin Béhé, Burkhard Göke, Klaus Joseph, Thomas M. Behr

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 5/2002

Title: Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results
Authors: Martin Gotthardt
Marc Fischer
Inga Naeher
Josefin B. Holz
Hartmut Jungclas
Hans-Walter Fritsch
Martin Béhé
Burkhard Göke
Klaus Joseph
Thomas M. Behr
Publication date: 01-05-2002
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 5/2002
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-002-0761-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 5/2002

Influence of rhTSH on [18F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma

Quantification of [123I]PE2I binding to dopamine transporters with SPET

Encyclopedic Reference of Cancer. 2001

Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson’s disease?

Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections

Atypical chest pain, myocardial perfusion SPET and left main stem occlusion